 | • レポートコード：QYR2104Z0239 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、アレルギー性喘息治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ASM-8、AXP-1275、ベータエスシン、CHF-6001、CSL-311、ダラザチド、その他）、用途別市場規模（クリニック、研究センター、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・アレルギー性喘息治療の市場動向 ・企業の競争状況、市場シェア ・アレルギー性喘息治療の種類別市場規模（ASM-8、AXP-1275、ベータエスシン、CHF-6001、CSL-311、ダラザチド、その他） ・アレルギー性喘息治療の用途別市場規模（クリニック、研究センター、病院、その他） ・アレルギー性喘息治療の北米市場規模2016-2027（アメリカ、カナダ） ・アレルギー性喘息治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・アレルギー性喘息治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アレルギー性喘息治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・アレルギー性喘息治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aslan Pharmaceuticals Pte. Ltd.、Axikin Pharmaceuticals, Inc.、Baxalta Incorporated、Chiesi Farmaceutici SpA、Circassia Pharmaceuticals Plc、CSL Limited、Fountain Biopharma Inc.、GlaxoSmithKline Plc、Hydra Biosciences, Inc.、Infinity Pharmaceuticals, Inc.、Kineta, Inc.、Mabtech Limited、Marinomed Biotechnologie GmbH、Mycenax Biotech Inc.、NeoPharm Co., Ltd.、Oxagen Limited、Panacea Biotec Limited） ・結論 |
Market Analysis and Insights: Global Allergic Asthma Therapeutics Market
The global Allergic Asthma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Allergic Asthma Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Allergic Asthma Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Allergic Asthma Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Allergic Asthma Therapeutics market.
Global Allergic Asthma Therapeutics Scope and Market Size
Allergic Asthma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Allergic Asthma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
ASM-8
AXP-1275
Beta-escin
CHF-6001
CSL-311
Dalazatide
Others
Segment by Application
Clinic
Research Center
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Aslan Pharmaceuticals Pte. Ltd.
Axikin Pharmaceuticals, Inc.
Baxalta Incorporated
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
CSL Limited
Fountain Biopharma Inc.
GlaxoSmithKline Plc
Hydra Biosciences, Inc.
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
Mabtech Limited
Marinomed Biotechnologie GmbH
Mycenax Biotech Inc.
NeoPharm Co., Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergic Asthma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ASM-8
1.2.3 AXP-1275
1.2.4 Beta-escin
1.2.5 CHF-6001
1.2.6 CSL-311
1.2.7 Dalazatide
1.2.8 Others
1.3 Market by Application
1.3.1 Global Allergic Asthma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Research Center
1.3.4 Hospital
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Allergic Asthma Therapeutics Market Perspective (2016-2027)
2.2 Allergic Asthma Therapeutics Growth Trends by Regions
2.2.1 Allergic Asthma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Allergic Asthma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Allergic Asthma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Allergic Asthma Therapeutics Industry Dynamic
2.3.1 Allergic Asthma Therapeutics Market Trends
2.3.2 Allergic Asthma Therapeutics Market Drivers
2.3.3 Allergic Asthma Therapeutics Market Challenges
2.3.4 Allergic Asthma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergic Asthma Therapeutics Players by Revenue
3.1.1 Global Top Allergic Asthma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Allergic Asthma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Allergic Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Allergic Asthma Therapeutics Revenue
3.4 Global Allergic Asthma Therapeutics Market Concentration Ratio
3.4.1 Global Allergic Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergic Asthma Therapeutics Revenue in 2020
3.5 Allergic Asthma Therapeutics Key Players Head office and Area Served
3.6 Key Players Allergic Asthma Therapeutics Product Solution and Service
3.7 Date of Enter into Allergic Asthma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergic Asthma Therapeutics Breakdown Data by Type
4.1 Global Allergic Asthma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2022-2027)
5 Allergic Asthma Therapeutics Breakdown Data by Application
5.1 Global Allergic Asthma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Allergic Asthma Therapeutics Market Size (2016-2027)
6.2 North America Allergic Asthma Therapeutics Market Size by Type
6.2.1 North America Allergic Asthma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Allergic Asthma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Allergic Asthma Therapeutics Market Size by Type (2016-2027)
6.3 North America Allergic Asthma Therapeutics Market Size by Application
6.3.1 North America Allergic Asthma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Allergic Asthma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Allergic Asthma Therapeutics Market Size by Application (2016-2027)
6.4 North America Allergic Asthma Therapeutics Market Size by Country
6.4.1 North America Allergic Asthma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Allergic Asthma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Allergic Asthma Therapeutics Market Size (2016-2027)
7.2 Europe Allergic Asthma Therapeutics Market Size by Type
7.2.1 Europe Allergic Asthma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Allergic Asthma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Allergic Asthma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Allergic Asthma Therapeutics Market Size by Application
7.3.1 Europe Allergic Asthma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Allergic Asthma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Allergic Asthma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Allergic Asthma Therapeutics Market Size by Country
7.4.1 Europe Allergic Asthma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Allergic Asthma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Allergic Asthma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Allergic Asthma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Allergic Asthma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Allergic Asthma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Allergic Asthma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Allergic Asthma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Allergic Asthma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Allergic Asthma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Allergic Asthma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Allergic Asthma Therapeutics Market Size (2016-2027)
9.2 Latin America Allergic Asthma Therapeutics Market Size by Type
9.2.1 Latin America Allergic Asthma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Allergic Asthma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Allergic Asthma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Allergic Asthma Therapeutics Market Size by Application
9.3.1 Latin America Allergic Asthma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Allergic Asthma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Allergic Asthma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Allergic Asthma Therapeutics Market Size by Country
9.4.1 Latin America Allergic Asthma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Allergic Asthma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergic Asthma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Allergic Asthma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Allergic Asthma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Allergic Asthma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Allergic Asthma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Allergic Asthma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Allergic Asthma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aslan Pharmaceuticals Pte. Ltd.
11.1.1 Aslan Pharmaceuticals Pte. Ltd. Company Details
11.1.2 Aslan Pharmaceuticals Pte. Ltd. Business Overview
11.1.3 Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Introduction
11.1.4 Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.1.5 Aslan Pharmaceuticals Pte. Ltd. Recent Development
11.2 Axikin Pharmaceuticals, Inc.
11.2.1 Axikin Pharmaceuticals, Inc. Company Details
11.2.2 Axikin Pharmaceuticals, Inc. Business Overview
11.2.3 Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.2.4 Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.2.5 Axikin Pharmaceuticals, Inc. Recent Development
11.3 Baxalta Incorporated
11.3.1 Baxalta Incorporated Company Details
11.3.2 Baxalta Incorporated Business Overview
11.3.3 Baxalta Incorporated Allergic Asthma Therapeutics Introduction
11.3.4 Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.3.5 Baxalta Incorporated Recent Development
11.4 Chiesi Farmaceutici SpA
11.4.1 Chiesi Farmaceutici SpA Company Details
11.4.2 Chiesi Farmaceutici SpA Business Overview
11.4.3 Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Introduction
11.4.4 Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.4.5 Chiesi Farmaceutici SpA Recent Development
11.5 Circassia Pharmaceuticals Plc
11.5.1 Circassia Pharmaceuticals Plc Company Details
11.5.2 Circassia Pharmaceuticals Plc Business Overview
11.5.3 Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Introduction
11.5.4 Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.5.5 Circassia Pharmaceuticals Plc Recent Development
11.6 CSL Limited
11.6.1 CSL Limited Company Details
11.6.2 CSL Limited Business Overview
11.6.3 CSL Limited Allergic Asthma Therapeutics Introduction
11.6.4 CSL Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.6.5 CSL Limited Recent Development
11.7 Fountain Biopharma Inc.
11.7.1 Fountain Biopharma Inc. Company Details
11.7.2 Fountain Biopharma Inc. Business Overview
11.7.3 Fountain Biopharma Inc. Allergic Asthma Therapeutics Introduction
11.7.4 Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.7.5 Fountain Biopharma Inc. Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Details
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Allergic Asthma Therapeutics Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Hydra Biosciences, Inc.
11.9.1 Hydra Biosciences, Inc. Company Details
11.9.2 Hydra Biosciences, Inc. Business Overview
11.9.3 Hydra Biosciences, Inc. Allergic Asthma Therapeutics Introduction
11.9.4 Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.9.5 Hydra Biosciences, Inc. Recent Development
11.10 Infinity Pharmaceuticals, Inc.
11.10.1 Infinity Pharmaceuticals, Inc. Company Details
11.10.2 Infinity Pharmaceuticals, Inc. Business Overview
11.10.3 Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Introduction
11.10.4 Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.10.5 Infinity Pharmaceuticals, Inc. Recent Development
11.11 Kineta, Inc.
11.11.1 Kineta, Inc. Company Details
11.11.2 Kineta, Inc. Business Overview
11.11.3 Kineta, Inc. Allergic Asthma Therapeutics Introduction
11.11.4 Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.11.5 Kineta, Inc. Recent Development
11.12 Mabtech Limited
11.12.1 Mabtech Limited Company Details
11.12.2 Mabtech Limited Business Overview
11.12.3 Mabtech Limited Allergic Asthma Therapeutics Introduction
11.12.4 Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.12.5 Mabtech Limited Recent Development
11.13 Marinomed Biotechnologie GmbH
11.13.1 Marinomed Biotechnologie GmbH Company Details
11.13.2 Marinomed Biotechnologie GmbH Business Overview
11.13.3 Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Introduction
11.13.4 Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.13.5 Marinomed Biotechnologie GmbH Recent Development
11.14 Mycenax Biotech Inc.
11.14.1 Mycenax Biotech Inc. Company Details
11.14.2 Mycenax Biotech Inc. Business Overview
11.14.3 Mycenax Biotech Inc. Allergic Asthma Therapeutics Introduction
11.14.4 Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.14.5 Mycenax Biotech Inc. Recent Development
11.15 NeoPharm Co., Ltd.
11.15.1 NeoPharm Co., Ltd. Company Details
11.15.2 NeoPharm Co., Ltd. Business Overview
11.15.3 NeoPharm Co., Ltd. Allergic Asthma Therapeutics Introduction
11.15.4 NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.15.5 NeoPharm Co., Ltd. Recent Development
11.16 Oxagen Limited
11.16.1 Oxagen Limited Company Details
11.16.2 Oxagen Limited Business Overview
11.16.3 Oxagen Limited Allergic Asthma Therapeutics Introduction
11.16.4 Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.16.5 Oxagen Limited Recent Development
11.17 Panacea Biotec Limited
11.17.1 Panacea Biotec Limited Company Details
11.17.2 Panacea Biotec Limited Business Overview
11.17.3 Panacea Biotec Limited Allergic Asthma Therapeutics Introduction
11.17.4 Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021)
11.17.5 Panacea Biotec Limited Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Allergic Asthma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ASM-8
Table 3. Key Players of AXP-1275
Table 4. Key Players of Beta-escin
Table 5. Key Players of CHF-6001
Table 6. Key Players of CSL-311
Table 7. Key Players of Dalazatide
Table 8. Key Players of Others
Table 9. Global Allergic Asthma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Allergic Asthma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Allergic Asthma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Allergic Asthma Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Allergic Asthma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Allergic Asthma Therapeutics Market Share by Regions (2022-2027)
Table 15. Allergic Asthma Therapeutics Market Trends
Table 16. Allergic Asthma Therapeutics Market Drivers
Table 17. Allergic Asthma Therapeutics Market Challenges
Table 18. Allergic Asthma Therapeutics Market Restraints
Table 19. Global Allergic Asthma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Allergic Asthma Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Asthma Therapeutics as of 2020)
Table 22. Ranking of Global Top Allergic Asthma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Allergic Asthma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Allergic Asthma Therapeutics Product Solution and Service
Table 26. Date of Enter into Allergic Asthma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Allergic Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Allergic Asthma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Allergic Asthma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Allergic Asthma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Allergic Asthma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Allergic Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Allergic Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Allergic Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Allergic Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Allergic Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Allergic Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Allergic Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Allergic Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Allergic Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Allergic Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Allergic Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Allergic Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Allergic Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Allergic Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Allergic Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Allergic Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Allergic Asthma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Allergic Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Allergic Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Allergic Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Allergic Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Allergic Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Allergic Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Allergic Asthma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Allergic Asthma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Allergic Asthma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Allergic Asthma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Allergic Asthma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Aslan Pharmaceuticals Pte. Ltd. Company Details
Table 67. Aslan Pharmaceuticals Pte. Ltd. Business Overview
Table 68. Aslan Pharmaceuticals Pte. Ltd. Allergic Asthma Therapeutics Product
Table 69. Aslan Pharmaceuticals Pte. Ltd. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Aslan Pharmaceuticals Pte. Ltd. Recent Development
Table 71. Axikin Pharmaceuticals, Inc. Company Details
Table 72. Axikin Pharmaceuticals, Inc. Business Overview
Table 73. Axikin Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
Table 74. Axikin Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Axikin Pharmaceuticals, Inc. Recent Development
Table 76. Baxalta Incorporated Company Details
Table 77. Baxalta Incorporated Business Overview
Table 78. Baxalta Incorporated Allergic Asthma Therapeutics Product
Table 79. Baxalta Incorporated Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Baxalta Incorporated Recent Development
Table 81. Chiesi Farmaceutici SpA Company Details
Table 82. Chiesi Farmaceutici SpA Business Overview
Table 83. Chiesi Farmaceutici SpA Allergic Asthma Therapeutics Product
Table 84. Chiesi Farmaceutici SpA Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Chiesi Farmaceutici SpA Recent Development
Table 86. Circassia Pharmaceuticals Plc Company Details
Table 87. Circassia Pharmaceuticals Plc Business Overview
Table 88. Circassia Pharmaceuticals Plc Allergic Asthma Therapeutics Product
Table 89. Circassia Pharmaceuticals Plc Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Circassia Pharmaceuticals Plc Recent Development
Table 91. CSL Limited Company Details
Table 92. CSL Limited Business Overview
Table 93. CSL Limited Allergic Asthma Therapeutics Product
Table 94. CSL Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 95. CSL Limited Recent Development
Table 96. Fountain Biopharma Inc. Company Details
Table 97. Fountain Biopharma Inc. Business Overview
Table 98. Fountain Biopharma Inc. Allergic Asthma Therapeutics Product
Table 99. Fountain Biopharma Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Fountain Biopharma Inc. Recent Development
Table 101. GlaxoSmithKline Plc Company Details
Table 102. GlaxoSmithKline Plc Business Overview
Table 103. GlaxoSmithKline Plc Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 104. GlaxoSmithKline Plc Recent Development
Table 105. Hydra Biosciences, Inc. Company Details
Table 106. Hydra Biosciences, Inc. Business Overview
Table 107. Hydra Biosciences, Inc. Allergic Asthma Therapeutics Product
Table 108. Hydra Biosciences, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Hydra Biosciences, Inc. Recent Development
Table 110. Infinity Pharmaceuticals, Inc. Company Details
Table 111. Infinity Pharmaceuticals, Inc. Business Overview
Table 112. Infinity Pharmaceuticals, Inc. Allergic Asthma Therapeutics Product
Table 113. Infinity Pharmaceuticals, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Infinity Pharmaceuticals, Inc. Recent Development
Table 115. Kineta, Inc. Company Details
Table 116. Kineta, Inc. Business Overview
Table 117. Kineta, Inc. Allergic Asthma Therapeutics Product
Table 118. Kineta, Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Kineta, Inc. Recent Development
Table 120. Mabtech Limited Company Details
Table 121. Mabtech Limited Business Overview
Table 122. Mabtech Limited Allergic Asthma Therapeutics Product
Table 123. Mabtech Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Mabtech Limited Recent Development
Table 125. Marinomed Biotechnologie GmbH Company Details
Table 126. Marinomed Biotechnologie GmbH Business Overview
Table 127. Marinomed Biotechnologie GmbH Allergic Asthma Therapeutics Product
Table 128. Marinomed Biotechnologie GmbH Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Marinomed Biotechnologie GmbH Recent Development
Table 130. Mycenax Biotech Inc. Company Details
Table 131. Mycenax Biotech Inc. Business Overview
Table 132. Mycenax Biotech Inc. Allergic Asthma Therapeutics Product
Table 133. Mycenax Biotech Inc. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Mycenax Biotech Inc. Recent Development
Table 135. NeoPharm Co., Ltd. Company Details
Table 136. NeoPharm Co., Ltd. Business Overview
Table 137. NeoPharm Co., Ltd. Allergic Asthma Therapeutics Product
Table 138. NeoPharm Co., Ltd. Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 139. NeoPharm Co., Ltd. Recent Development
Table 140. Oxagen Limited Company Details
Table 141. Oxagen Limited Business Overview
Table 142. Oxagen Limited Allergic Asthma Therapeutics Product
Table 143. Oxagen Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Oxagen Limited Recent Development
Table 145. Panacea Biotec Limited Company Details
Table 146. Panacea Biotec Limited Business Overview
Table 147. Panacea Biotec Limited Allergic Asthma Therapeutics Product
Table 148. Panacea Biotec Limited Revenue in Allergic Asthma Therapeutics Business (2016-2021) & (US$ Million)
Table 149. Panacea Biotec Limited Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allergic Asthma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. ASM-8 Features
Figure 3. AXP-1275 Features
Figure 4. Beta-escin Features
Figure 5. CHF-6001 Features
Figure 6. CSL-311 Features
Figure 7. Dalazatide Features
Figure 8. Others Features
Figure 9. Global Allergic Asthma Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Clinic Case Studies
Figure 11. Research Center Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Allergic Asthma Therapeutics Report Years Considered
Figure 15. Global Allergic Asthma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Allergic Asthma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Allergic Asthma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 18. Global Allergic Asthma Therapeutics Market Share by Regions (2022-2027)
Figure 19. Global Allergic Asthma Therapeutics Market Share by Players in 2020
Figure 20. Global Top Allergic Asthma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allergic Asthma Therapeutics as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Allergic Asthma Therapeutics Revenue in 2020
Figure 22. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 23. Global Allergic Asthma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 24. North America Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Allergic Asthma Therapeutics Market Share by Type (2016-2027)
Figure 26. North America Allergic Asthma Therapeutics Market Share by Application (2016-2027)
Figure 27. North America Allergic Asthma Therapeutics Market Share by Country (2016-2027)
Figure 28. United States Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Allergic Asthma Therapeutics Market Share by Type (2016-2027)
Figure 32. Europe Allergic Asthma Therapeutics Market Share by Application (2016-2027)
Figure 33. Europe Allergic Asthma Therapeutics Market Share by Country (2016-2027)
Figure 34. Germany Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Allergic Asthma Therapeutics Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Allergic Asthma Therapeutics Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Allergic Asthma Therapeutics Market Share by Region (2016-2027)
Figure 44. China Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Allergic Asthma Therapeutics Market Share by Type (2016-2027)
Figure 52. Latin America Allergic Asthma Therapeutics Market Share by Application (2016-2027)
Figure 53. Latin America Allergic Asthma Therapeutics Market Share by Country (2016-2027)
Figure 54. Mexico Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Allergic Asthma Therapeutics Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Allergic Asthma Therapeutics Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Allergic Asthma Therapeutics Market Share by Country (2016-2027)
Figure 60. Turkey Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Allergic Asthma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Aslan Pharmaceuticals Pte. Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 64. Axikin Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 65. Baxalta Incorporated Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 66. Chiesi Farmaceutici SpA Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 67. Circassia Pharmaceuticals Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 68. CSL Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 69. Fountain Biopharma Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 70. GlaxoSmithKline Plc Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 71. Hydra Biosciences, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 72. Infinity Pharmaceuticals, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 73. Kineta, Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 74. Mabtech Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 75. Marinomed Biotechnologie GmbH Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 76. Mycenax Biotech Inc. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 77. NeoPharm Co., Ltd. Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 78. Oxagen Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 79. Panacea Biotec Limited Revenue Growth Rate in Allergic Asthma Therapeutics Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界のアレルギー性結膜炎市場規模・現状・予測（2021年-2027年） Allergic conjunctivitis is an eye inflammation caused by an allergic reaction to substances like pollen or mold spores. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conj…- 世界のアレルギー性結膜炎市場規模・現状・予測（2021年-2027年） Allergic conjunctivitis is an eye inflammation caused by an allergic reaction to substances like pollen or mold spores. There are different types of allergic conjunctivitis such as seasonal allergic conjunctivitis, perennial allergic conjunctivitis, giant papillary conjunctivitis, vernal kerato conj…
- 世界の喘息治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Asthma Therapeutics Market The global Asthma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界のアレルギー性鼻炎治療市場規模・現状・予測（2021年-2027年） The common name for allergic rhinitis is hay fever. It is diagnosed when symptoms appear which includes itchy nose, mouth, eyes, throat, skin, as well as other parts of the body; along with this other symptoms includes running nose, sneezing, watery eyes, problem during smelling, cough and sore th…
- 世界のアレルギー性接触皮膚炎（ACDS）市場規模・現状・予測（2021年-2027年） Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The oth…